Imricor Medical Systems Inc
ASX:IMR
Net Margin
Imricor Medical Systems Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
|
Imricor Medical Systems Inc
ASX:IMR
|
372.8m AUD |
-3 095%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
230.4B USD |
32%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
168B USD |
29%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
155.4B USD |
14%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
147.5B USD |
12%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
118.1B USD |
14%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
53.5B EUR |
9%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
56.9B USD |
8%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
51.1B USD |
24%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.9B USD |
73%
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
42.2B USD |
27%
|
Imricor Medical Systems Inc
Glance View
Imricor Medical Systems, Inc. is a medical device company, which engages in the design, manufacture, and distribution of magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures. The company is headquartered in Burnsville, Minnesota. The company went IPO on 2019-08-30. The firm is engaged in designing, manufacturing, and selling MRI-compatible products for cardiac catheter ablation procedures to treat arrhythmias. Its products include Vision-mitral regurgitation (MR) Ablation Catheter, Advantage-MR electrophysiology (EP) Recorder/Stimulator and Vision-MR Dispersive Electrode. The Vision-MR Ablation Catheter is designed to work under real-time MRI guidance. Advantage-MR EP Recorder/Stimulator System provides technology that allows physicians to utilize both the EP recording system and a cardiac stimulator while ablating within the iCMR environment. The firm sells its products to hospitals and clinics for use in iCMR labs, in which ablation procedures using the Vision-MR Ablation Catheter can be performed.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Imricor Medical Systems Inc's most recent financial statements, the company has Net Margin of -3 094.9%.
You don't have any saved screeners yet